Free Trial

Synthomer (LON:SYNT) Share Price Passes Above Two Hundred Day Moving Average of $187.34

Synthomer plc (LON:SYNT - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 187.34 ($2.35) and traded as high as GBX 264.50 ($3.32). Synthomer shares last traded at GBX 260 ($3.27), with a volume of 246,465 shares traded.

Analyst Ratings Changes

Separately, Berenberg Bank reaffirmed a "buy" rating and issued a GBX 320 ($4.02) price target on shares of Synthomer in a research note on Wednesday, March 13th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of GBX 224.40 ($2.82).

View Our Latest Report on SYNT

Synthomer Trading Up 0.6 %

The company has a market cap of £427.74 million, a P/E ratio of -217.92, a P/E/G ratio of -0.17 and a beta of 1.78. The company has a quick ratio of 0.97, a current ratio of 1.95 and a debt-to-equity ratio of 79.72. The business has a 50-day moving average price of GBX 219.25 and a two-hundred day moving average price of GBX 187.86.

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

Featured Stories

Should you invest $1,000 in Synthomer right now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: